Skip to main content
# Title Research Year
141 METRONOMIC CAPECITABINE WITH VINORELBINE AS A SECOND LINE CHEMOTHERAPY IN ADVANCED BREAST CANCER 2015
142 Rate of thyroglossal duct remnant visualization
after total thyroidectomy for differentiated thyroid
carcinoma and its impact on clinical outcome of
radioactive iodine (I‑131) ablation
2015
143 Concurrent Radiochemotherapy in Locally Advanced Head and Neck Cancer: Analysis of Treatment Results and Prognostic factors 2015
144 Which is More Effective; Docetaxel, Doxorubicin
and Cyclophosphamide Or 5-Fluorouracil,
Doxorubicin and Cyclophosphamide in Adjuvant
Treatment of Early Stage Node Positive Breast
Cancer?
2015
145 GDP versus DHAP in relapsed and refractory Hodgkin disease 2015
146 Clinical Outcomes of Estrogen Negative- Progesterone Positive Invasive Breast Cancer, Retrospective Study 2015
147 Concurrent Radiochemotherapy in Locally Advanced Head and Neck Cancer: Analysis of Treatment Results and Prognostic factors 2015
148 Which is More Effective; Docetaxel, Doxorubicin
and Cyclophosphamide Or 5-Fluorouracil,
Doxorubicin and Cyclophosphamide in Adjuvant
Treatment of Early Stage Node Positive Breast
Cancer?
2015
149 GDP versus DHAP in relapsed and refractory Hodgkin disease 2015
150 Clinical Outcomes of Estrogen Negative- Progesterone Positive Invasive Breast Cancer, Retrospective Study 2015